BeyondSpring Inc. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by BeyondSpring Inc. on January 29, 2018, covering corporate governance events that occurred on January 2, 2018. The filing reports changes to the composition of the Board of Directors and the Audit Committee.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Board Appointments: Mr. Patrick Fabbio was appointed to the Board of Directors and the Audit Committee, serving as the chairman of the Audit Committee.
- Resignations: Dr. Nanxing He and Mr. Mulong Liu resigned from the Board and the Audit Committee.
- Committee Reassignment: Dr. Quanqi Song, a current independent Board member, was appointed to the Audit Committee.
Management Commentary and Compensation
Mr. Fabbio, previously the CFO of ElectroCore LLP and currently the CFO of Progenics Pharmaceuticals, Inc., was determined to satisfy the definition of an "independent director" under Nasdaq listing standards. The Audit Committee continues to consist solely of independent directors.
Mr. Fabbio's compensation package includes:
- Annual cash retainer: $30,000.
- Additional cash retainer for committee chairman: $3,750.
- Annual restricted share grant (value): $30,000.
- Additional restricted share grant for committee chairman (value): $3,750.
Mr. Fabbio also entered into the Company's standard indemnification agreement.
Key Facts for Investor Verification
- Verify the independence status of the new Audit Committee members under current Nasdaq listing standards.
- Confirm the effective date of the resignations of Dr. Nanxing He and Mr. Mulong Liu.
- Review the attached press release (Exhibit 99.1) for additional context on the leadership transition.
- Note that this filing contains no financial results; investors should refer to the most recent Form 20-F for financial data.